Marios Giannakis

Dr. Kimmie Ng says researchers are evaluating a range of factors that could be fueling a rise in colon cancer, everything from a lack of vitamin D, to the complicated role of the microbiome. CC: @KimmieNgMD @DFarberYoungCRC @NPR npr.org/sections/healt…

1/4 New Perspectives piece from Marios Giannakis and @KimmieNgMD of team OPTIMISTICC in @ScienceMagazine discusses the rising global incidence of early-onset colorectal cancer (EOCRC) science.org/doi/10.1126/sc…

I’m on the @ScienceMagazine weekly podcast to talk about the Perspective piece that @GiannakisLab and I wrote on #YoungOnsetColorectalCancer. Tune in to the conversation by clicking below! @DFarberYoungCRC @DanaFarber @DanaFarberNews

Must-read perspective by @GiannakisLab & @KimmieNgMD on the ongoing epidemic of early-onset colorectal cancer diagnoses. Reasons likely complex/multi factorial, in need of deep investigation in order to revert this concerning phenomenon. science.org/doi/10.1126/sc…

Young-onset #ColorectalCancer: A common cancer at an uncommon age. Publishing online in @ScienceMagazine, @DanaFarber's @KimmieNgMD and @GiannakisLab chart a course to better understand, prevent, and treat the disease. Read: bit.ly/3mTGtFP CC: @DFarberYoungCRC

Read more in the @ASCOPost on research into the effectiveness of a molecular tumor board in precision oncology for patients with gastrointestinal cancer treated at the Dana-Farber Brigham Cancer Center. CC: @DFarberYoungCRC @GiannakisLab Read more ➡️ bit.ly/3CYAg0r

New #ColorectalCancer research from #AACRcrc22 shows an oncogenic role and therapeutic options for one of the most frequent colorectal cancer mutations: RNF43 G659fs. Research presented by Dana-Farber's Marios Giannakis, MD, PhD (@GiannakisLab)

Excited to share our latest research showing an oncogenic role and therapeutic options for one of the most frequent Colorectal Cancer mutations @GiannakisLab @DanaFarber @broadinstitute nature.com/articles/s4146…

We are excited to share our study on spatially organized multicellular immune hubs in human colorectal cancer cell.com/cell/fulltext/… @CellCellPress. Joint effort with @karin_pelka, @chenchirps, @AnaAndersonlab, Orit Rozenblatt-Rosen, Aviv Regev, Nir Hacohen, many others!

Red meat and cancer 🥩 New research led by Dana-Farber's Marios Giannakis, MD, PhD, finds high red meat consumption may promote DNA damage-associated mutations in patients with #colorectalcancer, published in @CD_AACR: ms.spr.ly/6015nHLrx cc @DFarberYoungCRC

Colorectal cancer awareness month at the Dana-Farber Cancer Institute @DFarberYoungCRC

New research in @NatureComms: Resistance to immune checkpoint blocker drug linked to metabolic imbalance ms.spr.ly/6015TuH5P #KidneyCancer #Melanoma @DrChoueiri @GiannakisLab

Our work on immune-checkpoint inhibitor resistance in mismatch-repair deficient cancers may offer clues to new immunotherapy strategies in colorectal cancer cancerimmunolres.aacrjournals.org/content/early/…